CenterWatch

Clinical Trial Details

Overview

Research Study Summary

A randomized , double-blind, placebo-controlled , multicenter, two-part, dose ranging and confirmatory study with an operationally seamless design, evaluating efficacy and safety of IL-6Ra mAb on top of methotrexate in patients with active rheumatoid arthritis who are inadequate responders of MTX therapy.

Purpose

Do you have Rheumatoid arthritis? You may qualify to participate in a clinical research study.

IL-6Ra mAb is a randomized placebo controlled trial of an injectable IL-6Rmab for patient with active rheumatoid arthritis on methotrexate with active joint disease. There is 22 weeks of randomization followed by 58 weeks of open label extension.

To Learn more

CW ID:169938
Date Last Changed: July 23, 2013

Clinical Trial Snapshot

Phase
2
Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Duration
80 Weeks
Facility Type
N/A

Contact

The Center for Rheumatology and Bone Research
2730 University Blvd West, Suite 306
Wheaton, MD 20902
Phone: 301 942-6610
Fax: 301 942-7833

View Map

Research Center Information: The Center for Rheumatology and Bone Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.